Humacao, Puerto Rico Saturday, April 12, 2025, 11:00 Hrs [IST] ...

Aspire Biopharma (ASBP) announced initiation of its Phase 1 single- center clinical study of its lead therapeutic candidate, an oral ...

One clinical trial site activated Patient enrollment expected in April Trial designed to evaluate safety, pharmacokinetics ...

Researchers have discovered in a new study that high-dose aspirin does not significantly enhance coronary artery outcomes in ...